|
|
News Breaks | | | | October 4, 2012 | | 07:48 EDT |  | VRTX | Vertex catalysts begin next week, says Brean Murray
Brean Murray said next week's NACF conference should be the first of multiple upcoming catalysts coming for Vertex. The firm expects a comprehensive presentation on its cystic fibrosis drug and its probability of a successful Phase 3 outcome. Shares are Buy rated with a $69 price target. | |
|
News For VRTX From The Last 14 Days Check below for free stories on VRTX the last two weeks. |
|
|
| May 10, 2013 | | 14:02 EDT | | VRTX | Vertex to benefit from Welsh government decision, says Wells Fargo
 Subscribe for More Information | |
|
|
|
|
|
|
